Harmonization of IGF1 immunoassays towards a higher-order LC-MS/MS reference anchor

E G W M Lentjes1,2, M S Pratt3, I P Kema3

  • 1Central Diagnostic Laboratory, Utrecht University Medical Center, Utrecht, The Netherlands.

Endocrine Connections
|April 1, 2026
PubMed

Insights

Harmonizing insulin-like growth factor 1 (IGF1) immunoassays using higher-order reference materials significantly reduces inter-assay variability and improves patient classification. This approach enhances consistency across different testing platforms.

Area of Science:

  • Clinical Chemistry
  • Biomarker Measurement
  • Analytical Chemistry

Background:

  • Commercial insulin-like growth factor 1 (IGF1) immunoassays exhibit significant inter-assay variability despite universal calibration.
  • This variability leads to inconsistent patient classification and challenges in clinical interpretation.
  • Harmonization using a higher-order analytical anchor is proposed to mitigate these issues.

Purpose of the Study:

  • To develop and evaluate matrix-matched, commutable serum reference materials (RMs) for harmonizing IGF1 immunoassays.
  • To assess the impact of recalibration using a higher-order liquid chromatography-tandem mass spectrometry (LC-MS/MS) anchor on inter-assay variability.
  • To construct harmonized, age- and sex-specific reference intervals.

Main Methods:

  • Four multi-level, matrix-matched serum RMs were prepared and value-assigned using an LC-MS/MS method.
  • Commutability of RMs was assessed across four commercial immunoassays (Cobas, iSYS, Immulite, Liaison).
  • Deming regression was used to derive recalibration equations, and the reduction in standard error of estimate (SEE) was the primary endpoint.

Main Results:

  • Prior to recalibration, immunoassays showed positive bias up to 60% compared to LC-MS/MS.
  • Recalibration using commutable RMs significantly reduced pooled SEE by 37.4% in patient samples and 71.5% in healthy samples.
  • Cross-platform dispersion was substantially attenuated, although harmonization effects varied by assay.

Conclusions:

  • Matrix-matched, commutable RMs value-assigned by a higher-order LC-MS/MS method effectively reduce inter-assay bias and variability in IGF1 immunoassays.
  • Harmonization toward a higher-order analytical anchor is feasible in routine practice.
  • This approach provides a foundation for consistent cross-platform interpretation of IGF1 results.
Abstract

Related Concept Videos